BD announces the BD Intraosseous Vascular Access System to enable quick vascular access for critical care situations.
Vous n'êtes pas connecté
InspireMD announces the submission of the PMA application to the FDA for marketing approval of the CGuard Prime EPS.
BD announces the BD Intraosseous Vascular Access System to enable quick vascular access for critical care situations.
BD announces the BD Intraosseous Vascular Access System to enable quick vascular access for critical care situations.
LAKE TAHOE, Nev., Oct. 29, 2024 (GLOBE NEWSWIRE) — 2ONE Labs Inc., is pleased to announce the ‘Acceptance’ of its Premarket Tobacco Product...
LAKE TAHOE, Nev., Oct. 29, 2024 (GLOBE NEWSWIRE) — 2ONE Labs Inc., is pleased to announce the ‘Acceptance’ of its Premarket Tobacco Product...
LAKE TAHOE, Nev., Oct. 29, 2024 (GLOBE NEWSWIRE) — 2ONE Labs Inc., is pleased to announce the ‘Acceptance’ of its Premarket Tobacco Product...
LAKE TAHOE, Nev., Oct. 29, 2024 (GLOBE NEWSWIRE) — 2ONE Labs Inc., is pleased to announce the ‘Acceptance’ of its Premarket Tobacco Product...
LAKE TAHOE, Nev., Oct. 29, 2024 (GLOBE NEWSWIRE) — 2ONE Labs Inc., is pleased to announce the ‘Acceptance’ of its Premarket Tobacco Product...
LAKE TAHOE, Nev., Oct. 29, 2024 (GLOBE NEWSWIRE) — 2ONE Labs Inc., is pleased to announce the ‘Acceptance’ of its Premarket Tobacco Product...
LAKE TAHOE, Nev., Oct. 29, 2024 (GLOBE NEWSWIRE) — 2ONE Labs Inc., is pleased to announce the ‘Acceptance’ of its Premarket Tobacco Product...
CARLSBAD, Calif., Nov. 4, 2024 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) announced today that the U.S. Food and Drug Administration...